Ono Pharmaceutical Ltd (4528)

2,246.0 -26.0 (-1.14%)
Close JPY Disclaimer

4528 Financial Summary

Ono Pharmaceutical Co., Ltd. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 447,187 million. Basic earnings per share from continuing operations was JPY 230.85. Diluted earnings per share from continuing operations was JPY 230.79.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
4528
Gross margin TTM 74.71%
Operating margin TTM 31.82%
Net Profit margin TTM 25.46%
Return on Investment TTM 15.74%
Total Revenue
Net Income
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Revenue 112,769 131,190 138,697 120,016
Gross Profit 81,105 100,493 104,103 89,845
Operating Income 15,310 47,589 55,688 41,348
Net Income 17,433 36,052 42,673 31,818
Clear All
0Selected
Please try another search
4528
Quick Ratio MRQ 3.29
Current Ratio MRQ 3.99
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.12%
Total Assets
Total Liabilities
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Total Assets 913,668 891,725 895,918 871,878
Total Liabilities 115,063 101,045 112,630 103,430
Total Equity 798,605 790,680 783,288 768,448
Clear All
0Selected
Please try another search
4528
Cash Flow/Share TTM 235.59
Revenue/Share TTM 1,070.16
Operating Cash Flow 47.44%
Cash
Net Change in Cash
Title
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Cash From Operating Activities 49,162 24,777 46,359 -9,638
Cash From Investing Activities 28,704 -1,340 29,903 -9,190
Cash From Financing Activities -14,490 -28,711 -29,111 -17,536
Net Change in Cash 63,893 -5,457 47,272 -35,703
Clear All
0Selected
Please try another search

* In Millions of JPY (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles